跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,265 条关于
“Nav1.7 ASO”
全部
6,265
临床试验
2,413
药物
595
机构
132
资讯
3,125
去年
Quiver Bioscience Names Co-Founder Graham Dempsey CEO to Advance Nav1.7-Targeting ASO for Chronic Pain
去年
Quiver Bioscience Secures $2.15M NIH Grant to Develop AI-Powered CNS Drug Safety Platform
去年
Channel Therapeutics' NaV1.7 Inhibitor Shows Promising Results for Ocular Pain in Preclinical Trials
去年
Sarepta Therapeutics Halts Development of Vesleteplirsen for Duchenne Muscular Dystrophy
去年
Sarepta Halts Development of Vesleteplirsen for Duchenne Muscular Dystrophy
去年
SiteOne Therapeutics Raises $100M to Advance Non-Opioid Pain Therapies Targeting Sodium Channels
3个月前
SLC6A20-Targeting ASO Restores NMDA Receptor Function in Autism Models, Offering New Therapeutic Strategy
3个月前
ASO Targeting ZFP384 Sustains Microglial Repair Activity and Extends Stroke Recovery Window
3个月前
Servier Enrolls First Patient in Phase Ib/II Trial of ASO Therapy for KCNT1-Related Pediatric Epilepsy
5个月前
Pelthos Therapeutics Initiates Phase 1b/2a Trial of CT2000 Eye Drops for Chronic Ocular Pain in Dry Eye Disease
第 1 页,共 313 页
上一页
下一页